Evidence map›Paper›PMID 34893010›Full record

ArticleHuman vaccines & immunotherapeutics2021

Prevalence and genotype distribution of human papillomavirus infection among women aged 30-65 years in Xi'an, China: a population-based study of 14,655 women.

Xiaoxiao Han, Guozhong Song, Yufang Li, Zhaoqiang Dong, Xianchun Yan, Suqing Wang, Huizhen Tian, Xiaohong Wu, Chen Li, Yi Huo

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Trends of cancer mortality in Xi'an City, China: 2005-2020.Journal of cancer research and clinical oncology · 2022
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Xiaoxiao HanDepartment of Laboratory Medicine, Xi'an Maternal and Child Health Care Hospital, Xi'an, China.
Guozhong SongDepartment of Laboratory Medicine, Xi'an Maternal and Child Health Care Hospital, Xi'an, China.
Yufang LiNuclear Medicine Diagnostic Center, Shaanxi Provincial People's Hospital, Xi'an, China.
Zhaoqiang DongDepartment of Laboratory Medicine, Xi'an Maternal and Child Health Care Hospital, Xi'an, China.
Xianchun YanDepartment of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, China.
Suqing WangDepartment of Science and Education, Xi'an Maternal and Child Health Care Hospital, Xi'an, China.
Huizhen TianDepartment of Laboratory Medicine, Xi'an Maternal and Child Health Care Hospital, Xi'an, China.
Xiaohong WuDepartment of Women's Health, Xi'an Maternal and Child Health Care Hospital, Xi'an, China.
Chen LiDepartment of Women's Health, Xi'an Maternal and Child Health Care Hospital, Xi'an, China.
Yi HuoDepartment of Laboratory Medicine, 941 Hospital of Joint Logistics Support Force of PLA, Xining, China.ORCID 0000-0003-2144-4033
Northwest Women's and Children's Hospital · CNAir Force Medical University · CNPeople's Liberation Army 401 Hospital · CNShanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer is the fourth most common cancer among women worldwide in terms of both incidence and mortality. Persistent infection with high-risk human papillomavirus (HPV) has been identified as a cause of cervical intraepithelial neoplasia and invasive cervical cancer. The distribution of human papillomavirus genotypes varies regionally. To acquire baseline data on the population-based prevalence and genotype distribution of HPV infection, we investigated the molecular epidemiology of HPV infection among women in Xi'an, China. The study was conducted from September 2018 to December 2020. A total of 14,655 women aged 30-65 years were screened. The overall prevalence of HPV infection was 13.5% (95% confidence interval [CI]: 13.0-14.1%), with 10.4% of participants being positive for a single HPV type and 3.1% being positive for multiple HPV types. The prevalence of high-risk HPV (HR-HPV), low-risk HPV (LR-HPV) and mixed HPV infection was 10.1% (95% CI: 9.6-10.5%), 2.2% (95% CI: 2.0-2.4%), and 1.3% (95% CI: 1.1-1.5%), respectively. The five most frequently detected HR-HPV types were types 52 (2.6%), 16 (1.9%), 53 (1.8%), 58 (1.4%), and 51 (0.9%). The most frequently detected LR-HPV type was HPV-42 (1.1%). The prevalence and HPV genotype distribution varied by region and age. Age-specific HPV prevalence peaked in the over 60 years age group (18.8%), and Beilin District had the highest HPV prevalence (18.1%). The results of this first population-based study provide a reference for HPV-based cervical cancer screening and HPV vaccination programs in Xi'an.

Indexed as

Papillomavirus InfectionsUterine Cervical NeoplasmsChinaEarly Detection of CancerFemaleGenotypeHumansMiddle AgedPapillomaviridaePrevalencecervical cancer screeningChinageneral populationgenotype distributionHuman papillomavirus infectionprevalence survey

Identifiers

PMID34893010
PMCPMC8903934
OpenAlexW4200493313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.